EU trade mark deal struck, so what happens now?

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

EU trade mark deal struck, so what happens now?

Finally, after five years of debate, there is an agreement on reform to the EU Trade Marks Directive and CTM Regulation. While there is a cautious welcome for what has been agreed, we are likely to enter a new period of adaptation and scrutiny

EU flag

The so-called trilogue of the European Council, Commission and Parliament yesterday struck a deal on reforms to trade mark protection in Europe. As we reported yesterday, the substance of the reforms is probably less than many trade mark users hoped, and the latter stages of the negotiations were characterised by debates about money. There is also a lot of detail that still needs to be fleshed out.

Having said that, initial reaction to the agreement among trade mark groups has been cautiously positive. INTA President J Scott Evans (right) blogged that the Association “welcomes a number of aspects of the agreement” including the reduction in renewal fees, the provisions on goods in transit and the implementation of the IP Translator decision on classification of goods and services. But he added that there were elements of the deal that INTA would be monitoring.

Tove Graulund of Graulund Consulting, who chairs the MARQUES trade mark reform task force, added that elements of the agreement showed that users’ concerns had been listened to, in particular the plans to ensure all EU IP offices have administrative proceedings for trade mark cancellation and the financial incentive to apply for a CTM in just one class, rather than three.

However, EU member states have also got much of what they wanted from the negotiations. Notably, once the reform is implemented, at least €5 of every €100 received in fees by OHIM (which will be renamed the EU IP Office) will be “offset” to national offices to promote trade mark harmonisation. If OHIM continues to run at a significant surplus, this could increase to €10 in every €100. A further €15 in every €100 is earmarked for cooperation projects. That adds up to some nice extra revenue for national IP offices.

OHIM new office

Does that mean everyone is happy? The answer is that there is probably enough in the deal, based on what we have been told about it so far, to ensure the remaining formalities will be passed and it will lead to changes to trade mark practice in Europe.

That will end a process that began more than five years ago, with the Max Planck study (see our topic page for all the ups and downs of the process). But it will mark the beginning of another phase, which will be characterised by adaptation and observation.

Those who will have to adapt are trade mark practitioners and IP offices in Europe, though some countries will see bigger changes than others. And in truth for many trade mark owners and applicants the changes will be relatively minor and will have little impact on their day-to-day practice.

Meanwhile, trade mark users groups will be monitoring closely what happens to the money. The principle of diverting money away from OHIM was widely opposed, but that battle is now lost. Instead, users (some of whom are observers on OHIM’s Board) will want to see evidence that the money is staying in the IP system and being used to improve services for trade mark owners. IP offices in member states are on notice.

more from across site and SHARED ros bottom lb

More from across our site

Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
News of Via Licensing Alliance adding two new members and Nokia’s proposal to extend interim licences to Warner Bros Discovery and Paramount were also among the top talking points
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Cooley and Stikeman Elliott advised 35Pharma on the deal, which will allow GSK to get its hands on S235, an investigational medicine for pulmonary hypertension
Simon Wright explains why the UK should embrace the possibility of rejoining the UPC, and reveals how CIPA is reacting to this month’s historic Emotional Perception AI case at the UK Supreme Court
Matthew Grady of Wolf Greenfield says AI presents an opportunity in patent practice for stronger collaboration between in-house and outside counsel
Aparna Watal, head of trademarks at Halfords IP, discusses why lawyers must take a stand when advising clients and how she balances work, motherhood and mentoring
Discussion hosted by Bird & Bird partners also hears that UK courts’ desire to determine FRAND rates could see the jurisdiction penalised in a similar way to China
The platform’s proactive intellectual property enforcement helps brands spot and kill fakes, so they can focus on growth. Managing IP learns more about the programme
Hire of José María del Valle Escalante to lead the firm’s operations in ‘dynamic’ Catalonia and Aragon regions follows last month’s appointment of a new chief information officer
Gift this article